Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

We describe a mechanism of tumorigenesis mediated by kinase-dead BRAF in the presence of oncogenic RAS. We show that drugs that selectively inhibit BRAF drive RAS-dependent BRAF binding to CRAF, CRAF activation, and MEK–ERK signaling. This does not occur when oncogenic BRAF is inhibited, demonstrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidorn, Sonja J., Milagre, Carla, Whittaker, Steven, Nourry, Arnaud, Niculescu-Duvas, Ion, Dhomen, Nathalie, Hussain, Jahan, Reis-Filho, Jorge S., Springer, Caroline J., Pritchard, Catrin, Marais, Richard
Formato: Texto
Lenguaje:English
Publicado: Cell Press 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872605/
https://www.ncbi.nlm.nih.gov/pubmed/20141835
http://dx.doi.org/10.1016/j.cell.2009.12.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872605/
https://www.ncbi.nlm.nih.gov/pubmed/20141835
http://dx.doi.org/10.1016/j.cell.2009.12.040

Ejemplares similares